Sodium Lowering and Urinary Protein Reduction Trial
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 151 participants.
Also called NCT02945969
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 151 participants
- Sponsor
- Tulane University School of Public Health and Tropical Medicine
- Registry
-
NCT02945969
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02945969. Randomized; no masking; primary purpose prevention. Start 2016-11 (registry gives no type); primary completion 2021-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Sodium Lowering and Urinary Protein Reduction Trial
- Acronym
- SUPER
- Condition
- Chronic Kidney Disease
- Condition
- Albuminuria
- Intervention (Behavioral)
- Low Sodium Diet
- Lead sponsor
- Tulane University School of Public Health and Tropical Medicine
Record details
- Record id
cardio:ct-nct02945969- Content hash
5d75ca29f23381a16776436e994542098979158e70f965183962eb43a09e6e80